CR8862A - Derivados de polisacaridos y sus usos en la induccion de una respuesta inmune - Google Patents
Derivados de polisacaridos y sus usos en la induccion de una respuesta inmuneInfo
- Publication number
- CR8862A CR8862A CR8862A CR8862A CR8862A CR 8862 A CR8862 A CR 8862A CR 8862 A CR8862 A CR 8862A CR 8862 A CR8862 A CR 8862A CR 8862 A CR8862 A CR 8862A
- Authority
- CR
- Costa Rica
- Prior art keywords
- acetylated
- derivatives
- derivative
- polisacarids
- induction
- Prior art date
Links
- 230000028993 immune response Effects 0.000 title 1
- 230000006698 induction Effects 0.000 title 1
- 102000014914 Carrier Proteins Human genes 0.000 abstract 1
- 108010078791 Carrier Proteins Proteins 0.000 abstract 1
- 125000003047 N-acetyl group Chemical group 0.000 abstract 1
- 241000588650 Neisseria meningitidis Species 0.000 abstract 1
- 238000006640 acetylation reaction Methods 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 150000004676 glycans Chemical class 0.000 abstract 1
- 229930195733 hydrocarbon Natural products 0.000 abstract 1
- 150000002430 hydrocarbons Chemical class 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229920001282 polysaccharide Polymers 0.000 abstract 1
- 239000005017 polysaccharide Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0258—Escherichia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/185—Escherichia
- C12R2001/19—Escherichia coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/36—Neisseria
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Polymers & Plastics (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- General Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US58267204P | 2004-06-23 | 2004-06-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CR8862A true CR8862A (es) | 2007-07-24 |
Family
ID=35782376
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CR8862A CR8862A (es) | 2004-06-23 | 2007-01-18 | Derivados de polisacaridos y sus usos en la induccion de una respuesta inmune |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US7595307B2 (enExample) |
| EP (1) | EP1784428A2 (enExample) |
| JP (1) | JP2008509886A (enExample) |
| KR (1) | KR20070060069A (enExample) |
| AU (1) | AU2005258301A1 (enExample) |
| BR (1) | BRPI0512413A (enExample) |
| CA (1) | CA2568982A1 (enExample) |
| CR (1) | CR8862A (enExample) |
| EC (1) | ECSP077129A (enExample) |
| IL (1) | IL179642A0 (enExample) |
| MX (1) | MXPA06015107A (enExample) |
| NO (1) | NO20070434L (enExample) |
| RU (1) | RU2404995C2 (enExample) |
| WO (1) | WO2006002402A2 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8148335B2 (en) | 2004-06-23 | 2012-04-03 | Children's Hospital & Research Center Oakland | De-N-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapy |
| AU2005258301A1 (en) | 2004-06-23 | 2006-01-05 | Children's Hospital & Research Center At Oakland | Polysaccharide derivatives and uses in induction of an immune response |
| AU2006283302B2 (en) * | 2005-08-24 | 2012-11-15 | Novartis Vaccines And Diagnostics Srl | Zwitterionization of capsular saccharides |
| AU2006331634B2 (en) * | 2005-12-23 | 2013-01-10 | Children's Hospital & Research Center At Oakland | De-N-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapy |
| CA2692069C (en) * | 2007-06-20 | 2016-10-18 | Baxter Healthcare S.A. | Modified polysaccharides for conjugate vaccines |
| US8999954B2 (en) * | 2007-07-03 | 2015-04-07 | Childern's Hospital & Research Center at Oakland | Inhibitors of polysialic acid de-N-acetylase and methods for using the same |
| EP2173759A4 (en) * | 2007-07-03 | 2014-01-29 | Childrens Hosp & Res Ct Oak | OLIGOSIAL INSERTS, PROCESS FOR THEIR PREPARATION AND ITS IMMUNOLOGICAL USE |
| CA2692417C (en) | 2007-07-03 | 2017-03-21 | Children's Hospital & Research Center At Oakland | Polysialic acid derivatives, methods of production, and uses in enhancing cancer antigen production and targeting |
| WO2011133227A2 (en) | 2010-04-23 | 2011-10-27 | Ancora Pharmaceuticals Inc. | Synthetic oligosaccharides for staphyloccocus vaccine |
| US8716469B2 (en) | 2010-04-27 | 2014-05-06 | Ancora Pharmaceuticals, Inc. | Synthetic oligosaccharides for Moraxella vaccine |
| WO2011149778A1 (en) * | 2010-05-26 | 2011-12-01 | Ancora Pharmaceuticals Inc. | Synthetic oligosaccharides for neisseria meningitis vaccine |
| CN109182423B (zh) * | 2018-09-26 | 2020-07-07 | 武汉中科光谷绿色生物技术有限公司 | 促进大肠杆菌发酵生产聚唾液酸的方法 |
| CN112795583A (zh) * | 2020-11-16 | 2021-05-14 | 上海大学 | 重组唾液酸外切酶的制备方法、表达基因、重组表达载体及构建方法 |
| CN114507262B (zh) * | 2022-03-01 | 2023-12-19 | 德元堂(上海)健康科技发展有限公司 | 一种聚唾液酸的水解工艺 |
| CN114539333B (zh) * | 2022-03-01 | 2023-12-22 | 德元堂(上海)健康科技发展有限公司 | 一种唾液酸的循环生产工艺 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4314999A (en) * | 1978-07-31 | 1982-02-09 | Proter S.P.A. | N-Acyl derivatives of glucosamine having antitumor chemotherapeutic acitivity |
| US4216208A (en) * | 1978-07-31 | 1980-08-05 | Proter S.P.A. | N-Acyl derivatives of glucosamines having antitumor chemotherapeutic activity |
| US4727136A (en) | 1985-10-01 | 1988-02-23 | Canadian Patents And Development Ltd. | Modified meningococcal group B polysaccharide for conjugate vaccine |
| US4722136A (en) * | 1985-10-28 | 1988-02-02 | Leviton Manufacturing Company, Inc. | Snap-in convenience electrical connector system and method of assembly |
| JPS6344590A (ja) * | 1986-08-12 | 1988-02-25 | Mect Corp | シアル酸誘導体の製造方法 |
| ATE121947T1 (de) * | 1989-12-14 | 1995-05-15 | Ca Nat Research Council | Verbessertes meningokokkale polysaccharidkonjugatvakzin. |
| US5846951A (en) * | 1991-06-06 | 1998-12-08 | The School Of Pharmacy, University Of London | Pharmaceutical compositions |
| GB9116896D0 (en) * | 1991-08-06 | 1991-09-18 | Erba Carlo Spa | 3-deoxymannosamine derivatives and process for their preparation |
| US5811102A (en) | 1995-06-07 | 1998-09-22 | National Research Council Of Canada | Modified meningococcal polysaccharide conjugate vaccines |
| JPH101397A (ja) * | 1996-06-14 | 1998-01-06 | Mitsubishi Gas Chem Co Inc | 磁気光学素子の基板用ガーネット結晶及びその製造法 |
| US6048527A (en) | 1996-08-27 | 2000-04-11 | Chiron Corporation | Antibodies that define unique Meningococcal B epitopes and vaccine compositions |
| JP4162267B2 (ja) | 1996-08-27 | 2008-10-08 | カイロン コーポレイション | Ｎｅｉｓｓｅｒｉａ ｍｅｎｉｎｇｉｔｉｄｉｓ血清型Ｂ複合糖質およびその使用法 |
| EP1007546B1 (en) | 1997-08-27 | 2009-01-21 | Novartis Vaccines and Diagnostics, Inc. | Molecular mimetics of meningococcal b epitopes |
| AU5339699A (en) * | 1998-08-06 | 2000-02-28 | Johns Hopkins University School Of Medicine, The | Compounds for altering cell surface sialic acids and methods of use therefor |
| CA2279134A1 (en) | 1999-07-29 | 2001-01-29 | Tianmin Liu | Novel strategy for carbohydrate-based therapeutic vaccines |
| EP1307221A2 (en) | 2000-07-28 | 2003-05-07 | National Research Council of Canada | Modified sialic acid vaccines |
| AU2005258301A1 (en) | 2004-06-23 | 2006-01-05 | Children's Hospital & Research Center At Oakland | Polysaccharide derivatives and uses in induction of an immune response |
-
2005
- 2005-06-23 AU AU2005258301A patent/AU2005258301A1/en not_active Abandoned
- 2005-06-23 MX MXPA06015107A patent/MXPA06015107A/es not_active Application Discontinuation
- 2005-06-23 EP EP05767567A patent/EP1784428A2/en not_active Withdrawn
- 2005-06-23 BR BRPI0512413-1A patent/BRPI0512413A/pt not_active IP Right Cessation
- 2005-06-23 RU RU2007102255/05A patent/RU2404995C2/ru not_active IP Right Cessation
- 2005-06-23 CA CA002568982A patent/CA2568982A1/en not_active Abandoned
- 2005-06-23 US US11/166,781 patent/US7595307B2/en not_active Expired - Fee Related
- 2005-06-23 JP JP2007518334A patent/JP2008509886A/ja active Pending
- 2005-06-23 KR KR1020077001193A patent/KR20070060069A/ko not_active Ceased
- 2005-06-23 WO PCT/US2005/022590 patent/WO2006002402A2/en not_active Ceased
-
2006
- 2006-11-27 IL IL179642A patent/IL179642A0/en unknown
-
2007
- 2007-01-05 EC EC2007007129A patent/ECSP077129A/es unknown
- 2007-01-18 CR CR8862A patent/CR8862A/es not_active Application Discontinuation
- 2007-01-23 NO NO20070434A patent/NO20070434L/no not_active Application Discontinuation
-
2009
- 2009-08-12 US US12/540,249 patent/US20100068728A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0512413A (pt) | 2008-03-04 |
| US7595307B2 (en) | 2009-09-29 |
| AU2005258301A1 (en) | 2006-01-05 |
| RU2404995C2 (ru) | 2010-11-27 |
| EP1784428A2 (en) | 2007-05-16 |
| WO2006002402A3 (en) | 2006-05-04 |
| WO2006002402A2 (en) | 2006-01-05 |
| KR20070060069A (ko) | 2007-06-12 |
| ECSP077129A (enExample) | 2007-02-28 |
| US20070010482A1 (en) | 2007-01-11 |
| US20100068728A1 (en) | 2010-03-18 |
| IL179642A0 (en) | 2007-05-15 |
| CA2568982A1 (en) | 2006-01-05 |
| NO20070434L (no) | 2007-03-20 |
| JP2008509886A (ja) | 2008-04-03 |
| RU2007102255A (ru) | 2008-07-27 |
| MXPA06015107A (es) | 2007-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CR8862A (es) | Derivados de polisacaridos y sus usos en la induccion de una respuesta inmune | |
| BRPI0607374A2 (pt) | vacinas de vesìculas baseadas em gna1870 para proteção de amplo espectro contra doenças causadas por neisseria meningitidis | |
| ECSP11010975A (es) | Método de uso de una cepa de bacillus subtilis para mejorar la salud de animales | |
| PA8790201A1 (es) | Agentes citotóxicos que comprenden nuevos derivados de tomaimicina y su uso terapéutico | |
| BRPI0612670B8 (pt) | composição imunogênica, vacina a compreendendo e kit de vacina para a administração concomitante ou sequencial | |
| BRPI0412444B8 (pt) | fração de quil a com baixa toxidez e seu uso | |
| PE20080748A1 (es) | Vacuna a base de los de cepas de neisseria | |
| BRPI0515316A (pt) | compostos de imidazoquinolina | |
| BR112012004696B8 (pt) | composto modulador da atividade de tlr, seu uso, composição farmacêutica, medicamento, kit e combinação | |
| CO2023016246A2 (es) | Composiciones inmunógenas que comprenden antígenos de sacárido capsular conjugados y sus usos | |
| CL2004001550A1 (es) | Formula para infantes o para etapa siguiente del crecimiento, que comprende proteinas, lipidos, carbohidratos y un probiotico, en donde la fuente de lipidos incluye al menos un lc-pufa, y sus usos. | |
| CR10149A (es) | Agentes citotóxicos que comprenden nuevos derivados de tomaimicina y su uso terapéutico | |
| BRPI0519242A2 (pt) | uso derivados de 1-aminociclohexano para o tratamento de esclerose méltipla, instabilidade emocional e paralisia pseudobulbar | |
| EA201101164A1 (ru) | Иммуногенная композиция | |
| BR112013006396A2 (pt) | composições imunogênicas | |
| EA200601761A1 (ru) | Композиции в качестве адъювантов для усиления иммунных ответов на вакцины и способы их применения | |
| BR112015004515A2 (pt) | composição imunogênica | |
| NO20084752L (no) | Konjugater av aziridinayl-epotilonanaloger og farmasoytiske sammensetninger som inneholder disse | |
| CY1122051T1 (el) | Φαρμακευτικοι συνδυασμοι που περιλαμβανουν τεστοστερονη και ταδαλαφιλη για την θεραπεια της γυναικειας σεξουαλικης δυσλειτουργιας | |
| EA200870421A1 (ru) | Димеры производных артемизинина, их получение и их применение в терапии | |
| BR112015032200A2 (pt) | conjugado anticorpo-droga com estabilidade melhorada, método de preparação, composição farmacêutica e uso do mesmo | |
| BRPI0810130A8 (pt) | Composição de bebida, processo para produzir uma composição de bebida, e, uso de uma composição de bebida | |
| BRPI0411875A (pt) | método de imunização contra os sorogrupos a e c de neisseria meningitidis | |
| MX2010009147A (es) | Derivados de pirrolidinilo y usos de los mismos. | |
| BR112022003046A2 (pt) | Conjugados de il-15 e usos dos mesmos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal (granting procedure) |